Evidence map›Paper›PMID 34032340›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2021

COVID-19 in a kidney transplant recipient after mRNA-based SARS-CoV-2 vaccination.

Aris Tsalouchos, Gian Maria Rossolini, Laura Maggi, Alessio Mazzoni, Francesco Annunziato, Pietro Claudio Dattolo

Abstract readLetterComment
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  3. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Aris TsalouchosDepartment of Medicine, Division of Nephrology, Santa Maria Annunziata Hospital, Florence, Italy.ORCID 0000-0002-8565-4059
Gian Maria RossoliniDepartment of Clinical and Experimental Medicine, University of Florence, Florence, Italy.ORCID 0000-0002-9386-0434
Laura MaggiDepartment of Clinical and Experimental Medicine, University of Florence, Florence, Italy.ORCID 0000-0003-2862-9591
Alessio MazzoniDepartment of Clinical and Experimental Medicine, University of Florence, Florence, Italy.ORCID 0000-0001-7768-3805
Francesco AnnunziatoDepartment of Clinical and Experimental Medicine, University of Florence, Florence, Italy.ORCID 0000-0001-8798-7589
Pietro Claudio DattoloDepartment of Medicine, Division of Nephrology, Santa Maria Annunziata Hospital, Florence, Italy.ORCID 0000-0001-8355-6394

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Kidney TransplantationCOVID-19 VaccinesHumansRNA, MessengerSARS-CoV-2Transplant RecipientsVaccinationCOVID-19 VaccinesRNA, MessengerCOVID-19kidney transplantSARS-CoV-2 vaccination

Identifiers

PMID34032340
PMCPMC8209832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.